C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/10/2002	US6492490 Liquid phase peptide syntheses of KL-4 pulmonary surfactant
12/10/2002	US6492365 Microsomal triglyceride transfer protein
12/10/2002	US6492344 Syndecan enhancer element and syndecan stimulation of cellular differentiation
12/10/2002	US6492343 Porcine adenovirus type 3 genome
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492330 Antiangiogenic drugs
12/10/2002	US6492327 Isolation of purified TGF- β1 and TGF -β2 from bone tissue
12/10/2002	US6492324 APJ ligand polypeptides
12/10/2002	US6492177 Kit for use in treatment of polycystic ovarian disease
12/10/2002	US6492167 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects
12/10/2002	US6492165 Retrovirus isolated from humans
12/10/2002	US6492161 Bacteriophage RM 378 of a thermophilic host organism
12/10/2002	US6492151 The invention provides isolated nucleic acid and amino acid sequences of hskip3d, antibodies to hskip3d, methods of screening for hskip3d modulators using biologically active hskip3d, and kits for screening for hskip3d modulators.
12/10/2002	US6492148 A method for the preparation of an infectious ibdv mutant which will replicate in cef cell culture, comprising: separately preparing a dna construct comprising cdna of genome segments a and b of an ibdv which is not capable of
12/10/2002	US6492145 Vaccine against mycobacterial infections
12/10/2002	US6492143 A kit for amplification of olfactory receptor sequences comprising the primer pair; generating nucleic acid sequence that encodes a ligand-binding region of an olfactory receptor, the method comprising amplification of a nucleic acid using a
12/10/2002	US6492140 Polynucleotides encoding cytokine designated LERK-5
12/10/2002	US6492139 Human and rat smoothened, are provided. compositions including vertebrate smoothened chimeras, nucleic acid encoding vertebrate smoothened, and antibodies to vertebrate smoothened, are also provided.
12/10/2002	US6492138 Polynucleotides encoding a novel SHC-binding protein
12/10/2002	US6492137 Response element compositions and assays employing same
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002	US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease
12/10/2002	US6492124 Trance activated signal transduction pathways in osteoclasts
12/10/2002	US6492117 A cys2 his2 (cysteine2 histidine 2) zinc finger polypeptide that binds to a telomeric nucleic acid, a g-quadruplex nucleic acid, or a g-quartet nucleic acid; manipulating telomeres in vivo
12/10/2002	US6492110 Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1
12/10/2002	US6492105 Binding molecules for human factor VIII and factor VIII-like proteins
12/10/2002	US6492104 EIA test using nondenatured HIV antigen for early detection of HIV infection
12/10/2002	US6491926 35 kD tumor associated protein antigen: uses and methods of detection
12/10/2002	US6491924 Sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1
12/10/2002	US6491923 Stabilized conjugates of uncomplexed subunits of multimeric proteins
12/10/2002	US6491921 Nucleic acids immunology vectors comprising eukaryotic transcription or translation gene expression controllers having enhancers and codes for immunogen polypeptides used against infections
12/10/2002	US6491920 Polypeptides and DNA encoding same
12/10/2002	US6491909 Blocking antigen expression in genes of the major histocompatibility complex to prevent graft versus host dieases after grafting islets of langerhans; prophylaxis of diabetes mellitus
12/10/2002	US6491908 Selective elimination of T cells that recognize specific preselected targets
12/10/2002	US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells
12/10/2002	US6491871 System for determining receptor-ligand binding affinity
12/10/2002	US6491391 System, apparatus, and method for reducing birefringence
12/10/2002	CA2311684C Chemically-modified g-csf
12/10/2002	CA2257118C Recombinant blood-coagulation proteases
12/10/2002	CA2239195C Ceramic packing with channels for thermal and catalytic beds
12/10/2002	CA2196085C Mhc complexes and uses thereof
12/10/2002	CA2121147C Synthetic lung surfactant having antioxidant properties
12/10/2002	CA2114015C Recombinant antibodies for human therapy
12/10/2002	CA2085127C Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
12/10/2002	CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament
12/10/2002	CA2077764C Antibody to pacap and use thereof
12/10/2002	CA2047290C Recombinant marek's disease virus
12/10/2002	CA2038423C Process for preparing a purified treponemal antigen and use thereof
12/10/2002	CA1341407C Minactivin
12/08/2002	WO2003000892A1 Gene encoding b protein
12/08/2002	CA2398093A1 Gene encoding protein b
12/05/2002	WO2002097443A2 Method for diagnosing transmissable spongiform encephalopathy
12/05/2002	WO2002097441A2 Mammalian diabetes-mediating proteins
12/05/2002	WO2002097394A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor
12/05/2002	WO2002097136A1 Genetic markers for improved disease resistance in animals (bip)
12/05/2002	WO2002097134A2 Modified peptide nucleic acid
12/05/2002	WO2002097127A2 Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097117A2 Ipaf, an ice-protease activating factor
12/05/2002	WO2002097115A2 Xrcc1 and uses thereof
12/05/2002	WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF
12/05/2002	WO2002097104A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes
12/05/2002	WO2002097103A2 Constitutive plant promotor
12/05/2002	WO2002097099A1 Regulated expression of ghrh
12/05/2002	WO2002097096A2 Nucleotide sequences which code for the metd gene
12/05/2002	WO2002097095A1 Novel human transporter proteins and polynucleotides encoding the same
12/05/2002	WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	WO2002097093A1 Nucleic acids isolated in neuroblastoma
12/05/2002	WO2002097092A1 Neuronal cell-specific promoter
12/05/2002	WO2002097091A1 Generation of hcv-like particles and chimeric hcv virus
12/05/2002	WO2002097089A1 Microorganisms useful in industrial production
12/05/2002	WO2002097088A1 Testicular carnitine transporter and its gene
12/05/2002	WO2002097087A1 Method of expressing foreign gene in kidney
12/05/2002	WO2002097086A1 Industrially useful microorganisms
12/05/2002	WO2002097085A2 Callus specific plant promoters
12/05/2002	WO2002097082A2 Engineered biosynthesis of novel polyenes
12/05/2002	WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
12/05/2002	WO2002097072A2 Influenza vaccine composition
12/05/2002	WO2002097064A1 Host microorganisms
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097059A2 Chromosome-based platforms
12/05/2002	WO2002097057A2 Gene and polypeptide which opposes the fas pathyway
12/05/2002	WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002	WO2002097042A2 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
12/05/2002	WO2002097041A2 Fusion proteins of biologically active peptides and antibodies
12/05/2002	WO2002097038A2 Chemokine beta-1 fusion proteins
12/05/2002	WO2002097037A2 Melanin-concentrating hormone analogs
12/05/2002	WO2002097036A2 Compositions and methods for adipose abundant protein
12/05/2002	WO2002097035A2 Secreted proteins
12/05/2002	WO2002097034A2 Antibodies and antigens of hiv viremia controllers
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002097031A2 Molecules for diagnostics and therapeutics
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002	WO2002096951A1 Molecules for disease detection and treatment
12/05/2002	WO2002096947A2 The lectin-like domain of thrombomodulin and its therapeutic use
12/05/2002	WO2002096946A1 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy30

1 ... 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 ... 2916